Title

Blood Cancer Journal

Medilib Journal is a reliable source of researches and researches in the field of medicine. The philosophy of journals is to preserve scientific materials and register them in the name of the author and prevent plagiarism.

Blood Cancer Journal seeks to publish articles of the highest quality related to hematologic malignancies and related disorders. The Journal will consider for publication original research, reviews, guidelines and letters that are considered to be of high impact in the field. Topics of particular interest include, but are not limited to, the following: Preclinical studies of new compounds, especially those that provide mechanistic insights Clinical trials and observations Reviews related to new drugs and current management of hematologic malignancies Novel observations related to new mutations, molecular pathways, and tumor genomics.